Anthropic · Dario Amodei · TechCrunch AI
To that end, Anthropic also rolled out a Life Sciences Verification Program this week
Compiled by KHAO Editorial — aggregated from 1 source. See llms.txt for citation guidance.
◌ Single Source
It has also published recent reports on some of the research it’s doing to support drug discovery.
Key facts
- As investor and AI coding startup founder Chamath Palihapitiya posted on X, somewhat tongue in cheek: “The group behind such hits as: ‘They're All Going To Die’ and ‘Regulate Me Now’ are building a wet
- The fervor has grown so intense that CEO Dario Amodei published a post last weekend calling on the industry to slow down and institute self-regulation
- AI leaders have been promising that AI is the key to curing human disease
- To that end, Anthropic also launched a Life Sciences Verification Program this week, to give vetted bio researchers access to its most powerful models
Summary
Anthropic has a wet biology lab in the Bay Area where it can use its AI models to run physical experiments, it has confirmed to TechCrunch. AI leaders have been promising that AI is the key to curing human disease. “We believe that to do biology, the final test is still, and will be for a while, in real lab work,” Anthropic’s head of life sciences, Eric Kauderer-Abrams, told Reuters. While Anthropic declined to give specifics on what the wet lab is working on, it did say the main focus was fundamental biology, not drug discovery. Anthropic doesn’t want to give the appearance of competing with the pharma industry, where it has numerous major customers and partners (e.g., it announced a deal to work with Novo Nordisk on joint drug discovery).